Amgen, Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- One Amgen Center Drive, Thousand Oaks, California (CA) 91320, United States (USA)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 2026154 · DUNS 039976196
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIBioresearch Monitoring2025-08-07
- VAIDrug Quality Assurance2025-03-13
- NAIBioresearch Monitoring2023-09-14
- VAIDrug Quality Assurance2019-12-13
- NAIBioresearch Monitoring2017-04-19
- NAIDrug Quality Assurance2017-04-19
- NAIBioresearch Monitoring2017-03-17
- NAIBioresearch Monitoring2016-09-01
- NAIBioresearch Monitoring2016-04-13
- NAIBioresearch Monitoring2016-02-12
- VAIDrug Quality Assurance2015-05-22
- NAIBioresearch Monitoring2014-11-14
- NAIBioresearch Monitoring2014-09-17
- NAIBioresearch Monitoring2014-08-27
- NAIDrug Quality Assurance2014-08-27
- NAIBioresearch Monitoring2013-07-25
- NAIBioresearch Monitoring2012-12-12
- VAIBioresearch Monitoring2012-12-12
- VAIDrug Quality Assurance2012-12-12
- NAIBioresearch Monitoring2011-05-20
- NAIBioresearch Monitoring2010-11-17
- VAIBioresearch Monitoring2010-06-03
- NAIBioresearch Monitoring2009-05-01
Drugs this plant is listed as making
2 distinct drugs across 12 products name this site in their FDA label.
- adalimumab-attoAmgen USA Inc.
- ErythropoietinJanssen Products, LP
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.